氯胺酮治疗儿童难治性癫痫持续状态的研究进展

冯 晨晨1, 王 兰桂2
1、青海大学研究生院
2、青海大学附属医院神经内科

摘要


癫痫持续状态（status epilepticus，SE）是儿童最常见高发病率及高致残率的神经系统急症之一，目前尚无法
治愈。近年来针对氯胺酮（KE）作为一线麻醉剂被用来治疗儿童癫痫持续状态备受关注，本文现围绕氯胺酮的安全
性及有效性做一综述，以期为癫痫持续状态的治疗提供新选择。

关键词


癫痫持续状态；难治性癫痫持续状态；氯胺酮；安全性；有效性

全文:

PDF


参考


[1]Soto-Insuga, V., E. González-Alguacil and J.J.

García-Peñas, [Paediatric status epilepticus]. Rev Neurol,

2022. 75(8): p. 225-238.

[2]Samanta, D., L. Garrity and R. Arya, Refractory and

Super-refractory Status Epilepticus. Indian Pediatr, 2020.

57(3): p. 239-253.

[3]Fung, E., K.M. Yam and M. Yau, Ketamine use for

super-refractory status epilepticus in children. Hong Kong

Med J, 2020. 26(6): p. 549-550.

[4]Kuki, I., et al., Efficacy and safety of ketamine for

pediatric and adolescent super-refractory status epilepticus

and the effect of cerebral inflammatory conditions. J Neurol

Sci, 2024. 459: p. 122950.

[5]Williams, N.C., et al., Ketamine Efficacy for

Management of Status Epilepticus: Considerations for

Prehospital Clinicians. Air Med J, 2024. 43(2): p. 84-89.

[6]Coles, L., et al., Why ketamine. Epilepsy Behav,

2023. 141: p. 109066.

[7]Zhou, R., et al., Diazepam Monotherapy or

Diazepam-Ketamine Dual Therapy at Different Time Points

Terminates Seizures and Reduces Mortality in a Status

Epilepticus Animal Model. Med Sci Monit, 2021. 27: p.

e934043.

[8]Fung, E., K.M. Yam and M. Yau, Ketamine use for

super-refractory status epilepticus in children. Hong Kong

Med J, 2020. 26(6): p. 549-550.

[9]Soto-Insuga, V., E. González-Alguacil and J.J.

García-Peñas, [Paediatric status epilepticus]. Rev Neurol,

2022. 75(8): p. 225-238.

[10]Jacobwitz, M., et al., Ketamine for Management

of Neonatal and Pediatric Refractory Status Epilepticus.

Neurology, 2022. 99(12): p. e1227-e1238.

[11]Samanta, D., L. Garrity and R. Arya, Refractory

and Super-refractory Status Epilepticus. Indian Pediatr, 2020.

57(3): p. 239-253.

[12]Vossler, D.G., et al., Treatment of Refractory

Convulsive Status Epilepticus: A Comprehensive Review

by the American Epilepsy Society Treatments Committee.

Epilepsy Curr, 2020. 20(5): p. 245-264.

[13]Pin, J.N., et al., Efficacy and safety of ketamine

for neonatal refractory status epilepticus: case report and

systematic review. Front Pediatr, 2023. 11: p. 1189478.

[14]Guilliams, K.P. and D. Harrar, Ketamine for Status

Epilepticus in Children: Searching for the Right Drug for the

Right Patient. Neurocrit Care, 2024. 40(1): p. 45-47.

[15]Fung, E., K.M. Yam and M. Yau, Ketamine use for

super-refractory status epilepticus in children. Hong Kong

Med J, 2020. 26(6): p. 549-550.

[16]Kuki, I., et al., Efficacy and safety of ketamine for

pediatric and adolescent super-refractory status epilepticus

and the effect of cerebral inflammatory conditions. J Neurol

Sci, 2024. 459: p. 122950.

[17]Williams, N.C., et al., Ketamine Efficacy for

Management of Status Epilepticus: Considerations for

Prehospital Clinicians. Air Med J, 2024. 43(2): p. 84-89.

[18]Chiriboga, N., T. Spentzas and R. Abu-Sawwa, A

systematic review and meta-analysis of ketamine in pediatric

status epilepticus. Epilepsia, 2024.

[19]Perlmutter, M., et al., Prehospital Treatment of

Benzodiazepine-Resistant Pediatric Status Epilepticus with

Parenteral Ketamine: A Case Series. Prehosp Emerg Care,

2023. 27(7): p. 920-926.

[20]Samanta, D., L. Garrity and R. Arya, Refractory

and Super-refractory Status Epilepticus. Indian Pediatr, 2020.

57(3): p. 239-253.

[21]Wu, J., et al., [Effectiveness of ketamine in the

treatment of refractory and super-refractory status epilepticus in

children]. Zhonghua Er Ke Za Zhi, 2020. 58(4): p. 295-300.

[22]DeVine, M.N., S.E. Gordon and C.A. Press, Use

of Continuous Ketamine Infusion as an Adjunctive Agent in

Young Infants With Refractory and Super Refractory Status

Epilepticus: A Case Series. J Pediatr Pharmacol Ther, 2023.

28(2): p. 161-166.

[23]Huntsman, R.J., L. Strueby and W. Bingham,

Are Ketamine Infusions a Viable Therapeutic Option for

Refractory Neonatal Seizures? Pediatr Neurol, 2020. 103: p.

8-11.

[24]Benini, F., et al., Refractory symptoms in paediatric

palliative care: can ketamine help? Drugs Context, 2021. 10.

[25]Samanta, D., Ketamine in Refractory Neonatal

Seizures. Pediatr Neurol, 2020. 106: p. 76.

[26]Rossetti, A.O., J. Claassen and N. Gaspard, Status

epilepticus in the ICU. Intensive Care Med, 2024. 50(1): p.

1-16.

[27]Lee, S.K., Diagnosis and Treatment of Status

Epilepticus. J Epilepsy Res, 2020. 10(2): p. 45-54.

[28]Howing, C.E., F. Razi and W. Hakmeh, Resolution

of status epilepticus after ketamine administration. Am J

Emerg Med, 2022. 54: p. 328.e1-328.e2.

[29]Williams, N.C., et al., Ketamine Efficacy for

Management of Status Epilepticus: Considerations for

Prehospital Clinicians. Air Med J, 2024. 43(2): p. 84-89.

[30]Caranzano, L., J. Novy and A.O. Rossetti, Ketamine

in adult super-refractory status epilepticus: Efficacy analysis

on a prospective registry. Acta Neurol Scand, 2022. 145(6): p.

737-742.

[31]Dunn, E.J. and D.D. Willis, Ketamine for SuperRefractory Status Epilepticus in Palliative Care. A Case

Report and Review of the Literature. Am J Hosp Palliat Care,

2023: p. 10499091231215491.

[32]Tantillo, G., et al., Provider Experience With the

Use of Ketamine for Refractory Status Epilepticus. Clin

Neuropharmacol, 2024. 47(2): p. 37-43.

[33]Rosati, A., et al., KETASER01 protocol: What

went right and what went wrong. Epilepsia Open, 2022. 7(3):

p. 532-540.

[34]Finsterer, J., et al., Assessing the Effect of Ketamine

on Suprarefractory Status Epilepticus Requires Appropriately

Designed Cohort Studies. J Pediatr Pharmacol Ther, 2023.

28(6): p. 585-586.

[35]Jacobwitz, M., et al., Ketamine for Management

of Neonatal and Pediatric Refractory Status Epilepticus.

Neurology, 2022. 99(12): p. e1227-e1238.

[36]Alkhachroum, A., et al., Ketamine to treat superrefractory status epilepticus. Neurology, 2020. 95(16): p.

e2286-e2294.

[37]Buratti, S., et al., Ketamine as advanced secondline treatment in benzodiazepine-refractory convulsive status

epilepticus in children. Epilepsia, 2023. 64(4): p. 797-810.

[38]Jacobwitz, M., et al., A Comparison of Ketamine

and Midazolam as First-Line Anesthetic Infusions for

Pediatric Status Epilepticus. Neurocrit Care, 2024. 40(3): p.

984-995.

[39]Dunn, E.J. and D.D. Willis, Ketamine for SuperRefractory Status Epilepticus in Palliative Care. A Case

Report and Review of the Literature. Am J Hosp Palliat Care,

2023: p. 10499091231215491.

[40]陈克云，贾晓丹.负荷剂量氯胺酮治疗难治性癫

痫持续状态患儿的临床效果及预后研究[J].癫痫与神经电

生理学杂志，2021，30（04）：216-219.

[41]邓会芳，王博，孙婧，等.成人超难治性癫痫持

续状态治疗的研究进展[J].卒中与神经疾病，2024，31

（01）：109-112.

[42]陆钦池.癫痫持续状态药物治疗进展[J].中国现

代神经疾病杂志，2023，23（02）：104-109.

[43]邓会芳，孙婧，王博，等.神经重症患者非惊厥

性癫痫持续状态的早期预防及分步治疗研究进展[J].中国

现代医学杂志，2023，33（22）：43-47.


Refbacks

  • 当前没有refback。